Enzon Pharmaceuticals, Inc. (ENZND)
OTCMKTS · Delayed Price · Currency is USD
6.00
+0.45 (8.11%)
At close: Mar 27, 2026
Enzon Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
38.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 26.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 26.00K | -675.00K | -96.29% |
| Dec 31, 2021 | 701.00K | 649.00K | 1,248.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Luna Innovations | 116.61M |
| Woodlands Financial Services Company | 21.71M |
| Andover Bancorp | 18.22M |
| Middlebury National | 17.98M |
| Community Capital Bancshares | 12.68M |
| Shonghoya Intl Group | 5.52M |
| Alpha One | 3.72M |
| Easylink Solutions | 282.26K |